Triomics: Funding, Investors & Team (Sep 2026)
Triomics is a platform that uses AI to connect patients with clinical trials in the field of oncology. The company helps speed up trial enrollment, improve quality, and streamline healthcare operations. Its oncology AI is experienced in analyzing health records and medical jargon to support this important work.
Triomics has raised $37.0M across 3 funding rounds on record, the most recent a Series B of $22.0M announced in May 2026.
That round is above the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Triomics Company Profile and Key Stats
Latest funding round on record: May 2026.
Triomics Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Triomics raised $15.0M in a Series A announced in May 2024.
2 months later, an undisclosed round was announced in Jul 2024 with no disclosed amount.
1.8 years later, a Series B of $22.0M was announced in May 2026.
Triomics Founders and Leadership Team
No contact details are on record for this team yet.
Triomics Funding Compared to Other Artificial Intelligence Startups
Triomics' latest round of $22.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Triomics in Artificial Intelligence and San Francisco
Companies Similar to Triomics
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Triomics Funding FAQs
What does Triomics do?
Triomics is a platform that uses AI to connect patients with clinical trials in the field of oncology. The company helps speed up trial enrollment, improve quality, and streamline healthcare operations. Its oncology AI is experienced in analyzing health records and medical jargon to support this important work.
How much funding has Triomics raised?
Triomics has raised $37.0M across 3 rounds on record. The most recent is a Series B of $22.0M announced in May 2026.
When did Triomics last raise funding?
Triomics' most recent funding round on record is a Series B of $22.0M, announced in May 2026.
Who founded Triomics?
FundedIQ lists Hrituraj Singh (Founder), Sarim Khan (Founder) at Triomics.
Where is Triomics headquartered?
Triomics is based in San Francisco, California, United States.
How many employees does Triomics have?
Triomics is in the 101-250 employee band.
How does Triomics' funding compare to other Artificial Intelligence startups?
Triomics' latest round of $22.0M is above the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Triomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Triomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.